Do Hedge Funds and Insiders Love Sequenom, Inc. (SQNM)?

Page 1 of 2

Is it smart to be bullish on Sequenom, Inc. (NASDAQ:SQNM)?

If you were to ask many traders, hedge funds are seen as useless, outdated investment vehicles of a period lost to current times. Although there are over 8,000 hedge funds in operation in present day, this site focuses on the leaders of this group, close to 525 funds. It is widely held that this group has its hands on most of all hedge funds’ total capital, and by paying attention to their best stock picks, we’ve spotted a number of investment strategies that have historically outperformed the broader indices. Our small-cap hedge fund strategy outperformed the S&P 500 index by 18 percentage points a year for a decade in our back tests, and since we’ve began to sharing our picks with our subscribers at the end of August 2012, we have outperformed the S&P 500 index by 33 percentage points in 11 months (explore the details and some picks here).

Just as useful, optimistic insider trading sentiment is a second way to analyze the world of equities. As the old adage goes: there are a variety of incentives for an upper level exec to sell shares of his or her company, but just one, very simple reason why they would initiate a purchase. Many academic studies have demonstrated the impressive potential of this strategy if shareholders understand where to look (learn more here).

Sequenom, Inc. (NASDAQ:SQNM)

What’s more, let’s analyze the newest info surrounding Sequenom, Inc. (NASDAQ:SQNM).

What does the smart money think about Sequenom, Inc. (NASDAQ:SQNM)?

In preparation for the third quarter, a total of 16 of the hedge funds we track were long in this stock, a change of -6% from one quarter earlier. With hedgies’ sentiment swirling, there exists an “upper tier” of noteworthy hedge fund managers who were increasing their holdings significantly.

When using filings from the hedgies we track, William Leland Edwards’s Palo Alto Investors had the biggest position in Sequenom, Inc. (NASDAQ:SQNM), worth close to $34.5 million, comprising 4.1% of its total 13F portfolio. Sitting at the No. 2 spot is SAC Subsidiary of CR Intrinsic Investors, with a $25.6 million position; the fund has 0.9% of its 13F portfolio invested in the stock. Some other peers with similar optimism include Jerome Pfund and Michael Sjostrom’s Sectoral Asset Management, Steven Cohen’s SAC Capital Advisors and Samuel Isaly’s OrbiMed Advisors.

As Sequenom, Inc. (NASDAQ:SQNM) has faced dropping sentiment from the top-tier hedge fund industry, logic holds that there exists a select few fund managers who sold off their full holdings in Q1. At the top of the heap, Peter Kolchinsky’s RA Capital Management dumped the biggest position of the “upper crust” of funds we key on, totaling about $14.7 million in stock. Scott Burney’s fund, Bluefin Investment Management, also said goodbye to its stock, about $10.1 million worth. These moves are interesting, as aggregate hedge fund interest fell by 1 funds in Q1.

How are insiders trading Sequenom, Inc. (NASDAQ:SQNM)?

Insider buying made by high-level executives is best served when the company in question has seen transactions within the past half-year. Over the last half-year time frame, Sequenom, Inc. (NASDAQ:SQNM) has experienced zero unique insiders buying, and zero insider sales (see the details of insider trades here).

We’ll go over the relationship between both of these indicators in other stocks similar to Sequenom, Inc. (NASDAQ:SQNM). These stocks are ChemoCentryx Inc (NASDAQ:CCXI), Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI), Hyperion Therapeutics Inc (NASDAQ:HPTX), Emergent Biosolutions Inc (NYSE:EBS), and Idenix Pharmaceuticals Inc (NASDAQ:IDIX). This group of stocks are in the biotechnology industry and their market caps are closest to SQNM’s market cap.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!